alexa
Reach Us +1-504-608-2390
Interview | Amit K MaitinbspChemotherapy Open Access
ISSN: 2167-7700

Chemotherapy: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Amit K. Maiti
Amit K. Maiti

Executive Editor
Amit K. Maiti
Genetic epidemiology Unit
Department of A & I
Oklahoma Medical Res Foundation
USA
Tel. 405-271-8099
Read Interview session with Amit K. Maiti

 
Biography

I did PhD in yeast Molecular biology from Jadavpur University (Bose Institute), Kolkata, India. My postdoctoral studies comprised on genetics of left-right asymmetry in human in CRBM, France and Geneva University of Medical School in Switzerland with Prof P. Bouvagnet and Prof. Stylianos E. Antonarakis respectively. Then I moved to USA and worked on genetics and drug discovery in ovarian and lung cancer in University of Texas Medical Branch, Galveston with Prof. S. Mitra. Now I am a senior research scientist at OMRF, Oklahoma city and continue to work on genetics and drug discovery of autoimmune diseases, cancer and cardiovascular diseases. Multidrug resistance in cancer is a overwhelming problem in cancer and I developed a novel strategy to overcome drug resistance in cancer.

 
Research Interest

Population genetics, Genomics, System biology, Molecular biology of disease mechanism and drug development of autoimmune diseases, Cancer and Cardiovascular diseases.

Interview
1. How many years have you been associated with the current research?
15 years

2. What is the research topic you are working on now?
Genetics, genomics and molecular biology of human diseases, especially cancers, autoimmune and heart diseases. Drug development in cancer and heart failures.

3. What are attributes for a quality article?
Quality article is followed by the researchers and cited in their work.

4. Do you have any research funding (NIH or other national funding) now?
Not yet!

5. When did you become an editor of OMICS Journal?
2011

6. Where can the journal find the maximum scope in terms of niche?
It will take some time to create its own Niche!

7. What is your greatest career accomplishment?
-

8. How does the published scientific content assist the potential researchers?
Researchers in the field are highly benefited from the content of the paper published in chemotherapy.

9. What is the purpose of serving as an editor?
To make improve the journal and establish it as an important journal in the field.

10. Do you have any patents?
No

11. Have you contributed any editorials or papers (any types) to OMICS Journals in the past two years?
Yes

12. Do you plan to contribute any editorials or papers to OMICS Journals in the next year?
Yes

13. How would you define your experience with OMICS Group?
Excellent

14. Your opinion on conducting Editorial Board meetings at related Conferences?
Yes. We should push for more paper published in this journal and ask for PUBMED citation

15. Would you recommend OMICS to your friends or colleagues?
Yes

16. How do you differentiate Chemotherapy: Open access with other journals in the field?
I think chemotherapy is doing good and will come in future as an excellent journal in the field.
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri and Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

streamtajm

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version